Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.solara.co.in | |
Market Cap | 2,021.91 Cr. | |
Enterprise Value(EV) | 2,988.39 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -85.64 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.74 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 330.06 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 1.70 | Calculated using Price: 561.70 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 3.60 Cr. | 35,996,267 Shares |
FaceValue | 10 | |
About Solara Active Pharma Sciences Ltd. | ||
Solara Active Pharma Sciences is a dynamic, entrepreneurial and customer-oriented API manufacturer. It has a legacy of over three decades and trace its origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. The company is a global, R&D focused, pureplay API company engaged in the manufacturing and development of APIs and offering Contract Manufacturing and Development Services for global companies. |
1 Day |
|
+1.67% |
1 Week |
|
+32.53% |
1 Month |
|
+47.21% |
3 Month |
|
+40.76% |
6 Month |
|
+77.10% |
1 Year |
|
+54.49% |
2 Year |
|
-19.94% |
5 Year |
|
+39.92% |
10 Year |
|
6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0.78 | 8.32 | 12.48 | 17.23 | -3.75 | -1.47 | |
Return on Capital Employed (%) | 2.22 | 10.38 | 11.73 | 15.34 | -0.67 | 1.79 | |
Return on Assets (%) | 0.33 | 3.55 | 5.57 | 9.34 | -2.13 | -0.78 |
Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 764 | 956 | 1,086 | 1,589 | 1,525 | 1,500 | 1,463 | |
Non Curr. Liab. | 315 | 344 | 333 | 206 | 299 | 217 | 155 | |
Curr. Liab. | 738 | 656 | 730 | 789 | 1,063 | 1,101 | 1,165 | |
Minority Int. | 4 | 4 | 4 | 4 | 2 | 2 | 3 | |
Equity & Liab. | 1,821 | 1,960 | 2,153 | 2,588 | 2,890 | 2,821 | 2,787 | |
Non Curr. Assets | 1,214 | 1,312 | 1,481 | 1,530 | 1,651 | 1,633 | 1,592 | |
Curr. Assets | 608 | 648 | 672 | 1,058 | 1,239 | 1,188 | 1,195 | |
Misc. Exp. not W/O | ||||||||
Total Assets | 1,821 | 1,960 | 2,153 | 2,588 | 2,890 | 2,821 | 2,787 |
Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 521 | 1,387 | 1,322 | 1,617 | 1,268 | 1,444 | 1,407 | |
Other Income | 2 | 12 | 28 | 29 | 20 | 23 | 8 | |
Total Income | 523 | 1,399 | 1,349 | 1,646 | 1,288 | 1,466 | 1,415 | |
Total Expenditure | -458 | -1,166 | -1,062 | -1,231 | -1,188 | -1,310 | -1,463 | |
PBIDT | 65 | 233 | 287 | 415 | 100 | 156 | -48 | |
Interest | -25 | -82 | -78 | -84 | -75 | -90 | -96 | |
Depreciation | -34 | -83 | -94 | -109 | -112 | -111 | -105 | |
Taxation | 0 | -1 | 0 | 0 | 33 | 23 | 9 | |
Exceptional Items | -3 | -68 | ||||||
PAT | 6 | 67 | 115 | 221 | -58 | -22 | -308 | |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -1 | |
Share Associate | ||||||||
Other Related Items | ||||||||
Consolidated Net Profit | 0 | 60 | 115 | 221 | -58 | -22 | -308 | |
Adjusted EPS | 0 | 23 | 43 | 62 | -16 | -6 | -86 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 49 | 166 | 242 | 155 | -242 | 156 | |
Cash Fr. Inv. | -85 | -116 | -359 | -106 | -243 | -81 | |
Cash Fr. Finan. | 68 | -23 | 97 | 92 | 334 | -113 | |
Net Change | 31 | 27 | -20 | 142 | -151 | -38 | |
Cash & Cash Eqvt | 46 | 76 | 56 | 198 | 46 | 9 |
Tue, 23 Apr 2024
Price movement Significant movement in price has been observed in Solara Active Pharma Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Solara Active Pharma Sciences Limited has submitted their response. |
Mon, 22 Apr 2024
Price movement Significant movement in price has been observed in Solara Active Pharma Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
Mon, 22 Apr 2024
Disclosure under SEBI Takeover Regulations Solara Active Pharma Sciences Limitedᅡᅠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaᅡᅠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 |
Thu, 25 Apr 2024 |
Close Within 52 Week High Zone |
High Increase in 1 Month |
High Increase in 3 Months |
High Increase in 6 Months |
High Increase in 1 Year |